Therapy
Ipilimumab
Blocks CTLA-4, enhancing priming and depleting intratumoural Tregs.
In short
- 1What it is: a therapy in therapies and applications.
- 2How it connects: acts on 2 and is affected by 1 concepts — mostly 1 receptor, 1 disease, 1 trial.
- 3Where it sits: therapy on the 15-step immune chain.
What it does
Melanoma (with nivolumab); higher rate of colitis/hypophysitis than PD-1 blockade.
Its connections at a glance
Each dot is a concept directly linked to Ipilimumab. Colours show the kind of concept.
Sources & evidenceloading…
Loading reviewed sources…
Graph ID I025 · concept status: established. Select any connection above to inspect evidence for that specific link.